CRL vs GEN · rev $2.00B vs P/E 17, rev $5.00B
Charles River Laboratories (CRL) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
CRL currently screens at market cap $7.78B. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the CRL and GEN stock pages for the full models.
Not investment advice.